Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer.
Rachel HodanKerry KinghamKristina CotterAnn K FolkinsAllison W KurianJames M FordTeri LongacrePublished in: Cancer medicine (2020)
Most ovarian cancers with somatic MMR-D were confirmed to have LS in this cohort. Germline testing for LS in addition to BRCA1/2 for all women with an epithelial ovarian cancer would be efficient and would approach 100% sensitivity for identifying Lynch syndrome. Utilization of a multigene panel should also be considered, given the additional non-Lynch germline mutation identified in this cohort.